Abound Wealth Management
- SEC CIK
- 0001950323
- Latest filing
- Jul 10, 2026
CRL holding history
Charles River Laboratories International, Inc. in every 13F filed by Abound Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRL overviewAll 13F holders of CRLFull Q2 2026 holdings
- Shares (Q2 2026)
- 5
- Value
- $1.13K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5 | $1.13K | <0.1% | −2−28.6% | Reduced | Holders |
| Q1 2026 | 7 | $1.12K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 7 | $1.30K | <0.1% | +2+40.0% | Added | Holders |
| Q3 2025 | 5 | $783 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 5 | $759 | <0.1% | +5 | Added | Holders |
| Q1 2025 | 0 | $35 | <0.1% | −2−100.0% | Reduced | Holders |
| Q4 2024 | 2 | $338 | <0.1% | +1+100.0% | Added | Holders |
| Q3 2024 | 1 | $243 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1 | $255 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1 | $334 | <0.1% | +1 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −10−100.0% | Sold out | Holders |
| Q3 2023 | 10 | $1.96K | <0.1% | −1−9.1% | Reduced | Holders |
| Q2 2023 | 11 | $2.31K | <0.1% | +1+10.0% | Added | Holders |
| Q1 2023 | 10 | $2.02K | <0.1% | +10 | New | Holders |